Anika Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Anika Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Anika Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Anika Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $253k | 27k | 9.40 |
| 2025-03-31 | $558k | 37k | 15.03 |
| 2024-12-31 | $1.4M | 83k | 16.46 |
| 2024-09-30 | $383k | 16k | 24.70 |
| 2024-06-30 | $673k | 27k | 25.33 |
| 2024-03-31 | $695k | 27k | 25.40 |
| 2023-12-31 | $688k | 30k | 22.66 |
| 2023-09-30 | $267k | 14k | 18.63 |
| 2023-06-30 | $470k | 18k | 25.98 |
| 2023-03-31 | $109k | 3.8k | 28.79 |
| 2022-12-31 | $398k | 11k | 35.29 |
| 2022-06-30 | $218k | 9.8k | 22.32 |
| 2022-03-31 | $215k | 8.6k | 25.16 |
| 2021-12-31 | $349k | 9.8k | 35.64 |
| 2021-03-31 | $261k | 6.3k | 41.25 |
| 2020-12-31 | $406k | 9.0k | 45.29 |
| 2020-09-30 | $273k | 7.9k | 34.34 |
| 2020-06-30 | $242k | 7.3k | 32.97 |
| 2020-03-31 | $208k | 7.2k | 28.90 |
| 2019-12-31 | $380k | 7.3k | 51.74 |
| 2019-09-30 | $362k | 6.6k | 54.88 |
| 2019-06-30 | $293k | 6.6k | 44.44 |
| 2019-03-31 | $724k | 24k | 30.24 |
| 2018-12-31 | $704k | 21k | 33.54 |
| 2018-09-30 | $2.7M | 64k | 42.11 |
| 2018-06-30 | $286k | 8.9k | 32.13 |
| 2018-03-31 | $1.1M | 22k | 49.74 |
| 2017-12-31 | $1.7M | 31k | 53.68 |
| 2017-06-30 | $29k | 585 | 49.57 |
| 2017-03-31 | $1.5M | 35k | 43.82 |
| 2016-12-31 | $2.7M | 54k | 48.96 |
| 2016-09-30 | $551k | 12k | 47.87 |
| 2016-06-30 | $31k | 830 | 37.04 |
| 2016-03-31 | $8.4k | 228 | 37.04 |
| 2015-12-31 | $8.4k | 228 | 37.04 |
| 2013-12-31 | $566k | 15k | 38.17 |